Home / Guides / Medications
Medications

GLP-1 Drug Interactions: What Medications to Watch Out For

GLP-1 medications slow gastric emptying, which can change how your other drugs absorb. Here's the complete guide to interactions — what's safe, what needs monitoring, and what to time carefully.

Published May 6, 2026 · 12 min read
Last reviewed: May 6, 2026 by our editorial team. See our editorial process.

Bottom line

GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are generally safe to take alongside most common medications. But they slow gastric emptying — and that changes how quickly your body absorbs oral drugs. A few combinations require dose adjustments, closer monitoring, or careful timing. None of this is a reason to avoid GLP-1 therapy, but it is a reason to keep your prescriber and pharmacist in the loop about everything you take.

If you're starting a GLP-1 and currently take other medications, bring your full medication list to your prescriber. Most interactions are manageable with simple scheduling adjustments or more frequent lab monitoring.

The core mechanism: delayed gastric emptying

Every GLP-1 interaction story starts in the same place — your stomach.

GLP-1 receptor agonists slow the rate at which your stomach empties its contents into the small intestine. This is actually one of the ways these drugs help with weight loss: food sits in your stomach longer, you feel full sooner, and you eat less.

But medications are absorbed in the small intestine, not the stomach. When gastric emptying slows, oral medications spend more time in the acidic stomach environment and take longer to reach peak blood levels. For most drugs, this delay doesn't change the total amount absorbed — it just shifts the timing. But for medications with narrow therapeutic windows or time-sensitive absorption requirements, that shift matters.

This effect is strongest during the dose titration phase (the first 8–12 weeks) and tends to stabilize once you reach your maintenance dose. That's why most interaction concerns are highest when you're starting therapy or increasing your dose.

Injectable and IV medications bypass the gut entirely, so they are not affected by delayed gastric emptying.

Diabetes medications

If you're taking a GLP-1 for weight management and also have type 2 diabetes, the interaction with your existing diabetes medications is the most clinically important consideration.

Metformin

Generally safe to combine. Metformin and GLP-1s are one of the most common pairings in diabetes care, and the combination is well-studied. Metformin works through different mechanisms (hepatic glucose output, insulin sensitivity) and has a wide therapeutic window.

The practical consideration: as your GLP-1 therapy produces weight loss and improved insulin sensitivity, your A1C will drop. Your prescriber may need to reduce your metformin dose over time — not because of a drug interaction, but because you no longer need as much glucose-lowering medication. This is a good problem to have.

[drug:metformin]

Sulfonylureas (glipizide, glyburide, glimepiride)

Hypoglycemia risk — dose reduction often needed. Sulfonylureas stimulate insulin release regardless of blood glucose levels. When you add a GLP-1 that also enhances insulin secretion (in a glucose-dependent manner) and reduces food intake, the combination can push blood sugar too low.

Most prescribers will proactively reduce your sulfonylurea dose by 50% when starting a GLP-1, then adjust based on glucose monitoring. If you're on a sulfonylurea and your prescriber starts you on a GLP-1 without discussing a dose reduction, bring it up.

Signs of hypoglycemia to watch for: shakiness, sweating, confusion, rapid heartbeat, irritability, and extreme hunger. Keep glucose tablets or juice available during the titration period.

Insulin

Significant hypoglycemia risk — dose must be reduced. This is the highest-risk diabetes medication interaction with GLP-1s. Insulin directly lowers blood glucose, and adding a GLP-1 on top means you're hitting glucose from multiple directions while also eating significantly less.

Prescribers typically reduce basal insulin doses by 10–20% when initiating a GLP-1, with further reductions guided by glucose monitoring. Mealtime (bolus) insulin often needs even larger reductions because appetite suppression means smaller meals.

If you're on insulin and starting a GLP-1, your prescriber should give you a clear plan for dose adjustments and more frequent glucose monitoring. This is not a set-it-and-forget-it situation — it requires active management, especially during the first 3–6 months.

SGLT2 inhibitors (empagliflozin, dapagliflozin)

Generally safe. SGLT2 inhibitors work through the kidneys, not the gut, so absorption timing isn't an issue. The combination provides complementary glucose control and may offer additive cardiovascular and renal benefits. No specific dose adjustments are typically needed, but watch for increased urinary frequency and dehydration, especially as GLP-1 side effects like nausea can reduce fluid intake.

Blood pressure medications

GLP-1 therapy often leads to meaningful blood pressure reductions through weight loss alone — typically 3–8 mmHg systolic over the first 6 months. If you're already on antihypertensives, this means your current dose may become too much.

ACE inhibitors, ARBs, calcium channel blockers, and beta-blockers are all safe to combine with GLP-1s from an interaction standpoint. The concern isn't a drug-drug interaction — it's that you may need less blood pressure medication as you lose weight.

Monitor your blood pressure at home during the first 6 months of GLP-1 therapy. Symptoms of blood pressure that's dropped too low include dizziness (especially when standing), lightheadedness, and fatigue. Report these to your prescriber — they may reduce your antihypertensive dose, which is a sign your GLP-1 therapy is working.

Thyroid medications (levothyroxine)

Timing matters — monitor TSH more frequently. Levothyroxine has notoriously picky absorption requirements: it works best taken on an empty stomach, 30–60 minutes before food, with water only. Delayed gastric emptying can alter how quickly levothyroxine reaches the small intestine, where it's absorbed.

In practice, the clinical impact appears modest for most patients, but the FDA labeling for semaglutide notes that thyroid hormone levels should be monitored when co-administering.

Practical guidance:

[drug:levothyroxine]

Oral contraceptives

Absorption may be delayed — clinical significance is unclear. The FDA labeling for some GLP-1s recommends caution with oral contraceptives because delayed gastric emptying could theoretically reduce absorption of the hormones, particularly time-sensitive formulations.

The real-world evidence is reassuring: large studies have not shown increased pregnancy rates among GLP-1 users on oral contraceptives. However, the theoretical concern is reasonable enough that many prescribers recommend a practical approach.

Practical guidance:

Worth noting: GLP-1s may also improve fertility by improving ovulatory function in patients with PCOS or obesity-related anovulation. If you could become pregnant and don't want to, this is worth discussing with your prescriber regardless of the contraceptive interaction question.

Blood thinners (warfarin)

Monitor INR more closely. Warfarin has a very narrow therapeutic window — the difference between too little (clot risk) and too much (bleeding risk) is small. Any change in absorption timing can shift INR values.

Delayed gastric emptying from GLP-1s could alter how quickly warfarin reaches peak blood levels. Additionally, dietary changes (eating less, eating differently) can affect warfarin metabolism because vitamin K intake directly influences warfarin's effectiveness.

Practical guidance:

Psychiatric medications

SSRIs and SNRIs

Generally safe to combine. Antidepressants like sertraline, escitalopram, fluoxetine, venlafaxine, and duloxetine are commonly taken alongside GLP-1s without clinically significant interactions. Absorption timing may shift slightly, but these medications have wide enough therapeutic windows that this rarely matters.

One consideration: some SSRIs can cause weight gain, while GLP-1s cause weight loss. Your prescriber may want to reassess whether your current antidepressant is the best fit if weight is a priority. Some SSRIs (notably bupropion) are weight-neutral or even promote modest weight loss.

Mood stabilizers (lithium, valproate)

Lithium requires monitoring. Lithium has a narrow therapeutic window similar to warfarin. Dehydration from GLP-1 side effects (nausea, vomiting, diarrhea) can increase lithium levels dangerously. If you're on lithium and starting a GLP-1, your prescriber should check lithium levels more frequently during titration and emphasize the importance of staying hydrated.

Valproate is less concerning but also benefits from periodic level checks.

Stimulants and appetite suppressants

If you're on stimulant medications for ADHD (methylphenidate, amphetamine salts) or the weight-loss drug phentermine, combining with a GLP-1 adds another appetite-suppressing agent. This isn't a pharmacokinetic interaction — the drugs don't interfere with each other's absorption — but the combined appetite suppression can be profound. Make sure you're eating enough to meet basic nutritional needs.

OTC medications and supplements

NSAIDs (ibuprofen, naproxen, aspirin)

Use with caution. GLP-1 side effects already stress the GI tract (nausea, vomiting). NSAIDs independently increase the risk of gastric ulcers and GI bleeding. The combination raises the baseline GI risk. For occasional use, this is manageable — but if you're taking NSAIDs regularly, talk to your prescriber about alternatives like acetaminophen (Tylenol) for pain relief.

Antacids and acid reducers

Generally safe, but timing matters. PPIs (omeprazole, pantoprazole) and H2 blockers (famotidine) are fine to combine and may even help manage GLP-1-related nausea and reflux. Antacids (Tums, Maalox) are also fine but work best when taken as needed rather than scheduled.

Vitamins and supplements

The delayed gastric emptying principle applies to supplements as well. Fat-soluble vitamins (A, D, E, K) and minerals like iron, calcium, and magnesium may absorb slightly differently. This is rarely clinically significant, but if you're being treated for a deficiency, your prescriber should check levels after you've been on a stable GLP-1 dose for 2–3 months.

Practical guidance for supplements:

Alcohol

Alcohol isn't a medication, but it interacts with GLP-1 therapy in ways worth noting.

Blood sugar effects: Alcohol can lower blood sugar, and combined with a GLP-1 (especially if you're also on insulin or sulfonylureas), this increases hypoglycemia risk. Eat something when you drink.

GI effects: Many GLP-1 users report that alcohol tolerance drops significantly. Nausea and vomiting are more likely. Some patients find that even small amounts of alcohol cause discomfort that didn't exist before therapy.

Caloric considerations: Alcohol provides empty calories that can offset the weight-loss benefits of GLP-1 therapy. Many prescribers counsel patients to reduce alcohol intake while on these medications — not because of a pharmacological interaction, but because it works against your goals.

Pancreatitis risk: GLP-1s carry a small theoretical risk of pancreatitis, and heavy alcohol use is an independent risk factor. The combination may increase risk, though this hasn't been definitively established.

The FDA's position

The FDA's prescribing information for semaglutide and tirzepatide acknowledges the delayed gastric emptying effect and its potential to alter absorption of oral medications. However, the agency has not issued specific contraindications for any commonly prescribed drug combinations.

The labeling recommends:

In practice, this means the FDA views these interactions as manageable with appropriate monitoring rather than as reasons to avoid GLP-1 therapy.

Practical medication scheduling guide

Here's a framework for timing your medications when you're on a GLP-1. Consult your prescriber for your specific regimen.

| When | What to take | Why | |---|---|---| | Morning, empty stomach | Levothyroxine | Needs empty stomach for absorption | | 30–60 min later, with breakfast | Metformin, blood pressure meds, SSRIs | Stable absorption, reduced GI upset | | Midday | Second-dose medications as prescribed | Spread out the GI load | | Evening | Statins (if evening-dosed), supplements | Separates from morning medications | | GLP-1 injection day | Take injection at your usual scheduled time | Consistency matters more than time of day |

General principles:

When to talk to your pharmacist vs. your prescriber

Talk to your pharmacist when you:

Talk to your prescriber when you:

[guide:medication-timing]

The most important thing you can do is keep every member of your care team — prescriber, pharmacist, and any specialists — informed that you're on a GLP-1 medication. Most interactions are straightforward to manage once everyone knows what you're taking.